Prevalence of age-related macular degeneration in a large European cohort: Results from the population-based Gutenberg Health Study

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 252, Issue 9, 2014, Pages 1403-1411

  Korb, Christina A ^a   Kottler, Ulrike B ^a   Wolfram, Christian ^a   Hoehn, René ^a   Schulz, Andreas ^a   Zwiener, Isabella ^a   Wild, Philipp S ^a,b   Pfeiffer, Norbert ^a   Mirshahi, Alireza ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Age related macular degeneration; Age related maculopathy; Epidemiology; Population based study; Prevalence

Indexed keywords

EID: 84894247919     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-014-2591-9     Document Type: Article

References (42)

1. Bourla DH, Young TA (2006) Age-related macular degeneration: a practical approach to a challenging disease. J Am Geriatr Soc 54:1130–1135
2. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY (2012) Age-related macular degeneration. Lancet 379:1728–1738
3. Heijl A, Algvere PV, Alm A, Andersen N, Bauer B, Carlsson JO, Ehinger B, Eide N, Fledelius H, Foerster M, Hjortdal J, Holmstrom G, Hovding G, Kivela T, la Cour M, Lindblom B, Moller-Pedersen T, Nikoskelainen E, Prause JU, Riise R, Rosenberg T, Seregard S, Stefansson E, Tarkkanen A, Tervo T, Tornqvist K, Zetterstrom C (2005) Nordic research in ophthalmology. Acta Ophthalmol Scand 83:278–288
4. Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99:933–943
5. Finger RP, Fimmers R, Holz FG, Scholl HP (2011) Prevalence and causes of registered blindness in the largest federal state of Germany. Br J Ophthalmol 95:1061–1067
6. Krumpaszky HG, Klauss V (1996) Epidemiology of blindness and eye disease. Ophthalmologica 210:1–84
7. Hoehn R, Mirshahi A, Hoffmann EM, Kottler UB, Wild PS, Laubert-Reh D, Pfeiffer N (2013) Distribution of Intraocular Pressure and Its Association with Ocular Features and Cardiovascular Risk Factors: The Gutenberg Health Study. Ophthalmology 120(5):961–968
8. Mirshahi A, Ponto KA, Hohn R, Wild PS, Pfeiffer N (2013) Ophthalmological aspects of the Gutenberg Health Study (GHS): An interdisciplinary prospective population-based cohort study. Ophthalmologe 110:210–217
9. Wild PS, Zeller T, Beutel M, Blettner M, Dugi KA, Lackner KJ, Pfeiffer N, Munzel T, Blankenberg S (2012) The Gutenberg Health Study. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 55:824–829
10. Stang A, Ahrens W, Jockel KH (1999) Control response proportions in population-based case–control studies in Germany. Epidemiology 10:181–183
11. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R et al (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39:367–374
12. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
13. Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844–851
14. Erke MG, Bertelsen G, Peto T, Sjolie AK, Lindekleiv H, Njolstad I (2012) Prevalence of age-related macular degeneration in elderly Caucasians: the Tromso Eye Study. Ophthalmology 119:1737–1743
15. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, de Jong PT (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102:205–210
16. Mitchell P, Smith W, Attebo K, Wang JJ (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102:1450–1460
17. Augood CA, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Bentham G, Rahu M, Vioque J, Young IS, Fletcher AE (2006) Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 124:529–535
18. Klein R, Klein BE, Tomany SC, Moss SE (2002) Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol 156:589–598
19. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT (1998) Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 116:653–658
20. Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Nieto FJ, Huang GH, Pankow JS, Klein BE (2010) The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 128:750–758
21. Kawasaki R, Wang JJ, Ji GJ, Taylor B, Oizumi T, Daimon M, Kato T, Kawata S, Kayama T, Tano Y, Mitchell P, Yamashita H, Wong TY (2008) Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalmology 115:1376–1381, 1381 e1371-1372
22. Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB, Wang JJ, Mitchell P, Wong TY (2010) The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 117:921–927
23. Cheung CM, Tai ES, Kawasaki R, Tay WT, Lee JL, Hamzah H, Wong TY (2012) Prevalence of and risk factors for age-related macular degeneration in a multiethnic Asian cohort. Arch Ophthalmol 130:480–486
24. Piermarocchi S, Segato T, Scopa P, Masetto M, Ceca S, Cavarzeran F, Peto T (2011) The prevalence of age-related macular degeneration in Italy (PAMDI) study: report 1. Ophthalmic Epidemiol 18:129–136
25. Cruickshanks KJ, Klein R, Klein BE, Nondahl DM (2001) Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study. Arch Ophthalmol 119:246–250
26. Fletcher AE, Bentham GC, Agnew M, Young IS, Augood C, Chakravarthy U, de Jong PT, Rahu M, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Vingerling JR, Vioque J (2008) Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol 126:1396–1403
27. Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, Klein BE, Smith W, De Jong PT (2004) Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 111:1280–1287
28. Buch H, Nielsen NV, Vinding T, Jensen GB, Prause JU, la Cour M (2005) 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology 112:787–798
29. Tomany SC, Klein R, Klein BE (2003) The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 110:1526–1533
30. Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N (1986) Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 93:552–558
31. Hyman LG, Lilienfeld AM, Ferris FL 3rd, Fine SL (1983) Senile macular degeneration: a case–control study. Am J Epidemiol 118:213–227
32. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PT (2001) Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 108:697–704
33. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10:31. doi:10.1186/1471-2415-10-31
34. Mitchell P, Smith W, Wang JJ (1998) Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study. Ophthalmology 105:1359–1363
35. Vinding T (1990) Pigmentation of the eye and hair in relation to age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 68:53–58
36. Klein R, Klein BE, Jensen SC, Cruickshanks KJ (1998) The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 116:506–513
37. Munch IC, Ek J, Kessel L, Sander B, Almind GJ, Brondum-Nielsen K, Linneberg A, Larsen M (2010) Small, hard macular drusen and peripheral drusen: associations with AMD genotypes in the Inter99 Eye Study. Invest Ophthalmol Vis Sci 51:2317–2321
38. Klein R, Clegg L, Cooper LS, Hubbard LD, Klein BE, King WN, Folsom AR (1999) Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 117:1203–1210
39. Kawasaki R, Wang JJ, Aung T, Tan DT, Mitchell P, Sandar M, Saw SM, Wong TY (2008) Prevalence of age-related macular degeneration in a Malay population: the Singapore Malay Eye Study. Ophthalmology 115:1735–1741
40. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98:1128–1134
41. Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG (2012) Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119:571–580
42. Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF (2010) Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 117:1775–1781